Lord's Mark Industries Ltd. has secured Central Licensing Authority approval for its LordsMed HIV 1&2 Self Test, becoming one of nine global companies with this Class D in-vitro diagnostic self-test clearance. The company will commence exports to Africa, the EU, and South America in June 2026, targeting key international markets.